A Comparison of Elan, Biogen and Antegren Companies (2063 words, 8 pages)
Antegren A Beacon of HopeStakeholders for the decision to pursue early approval for Antegren are the company itself and its shareholders, Jim Mullen and other Biogen employees, the patient community, the FDA, Elan and its shareholders, insurers, and managed care providers. While all of the stakeholders mentioned above want to ...
Read More